View Item 

Show simple item record

Y-Maze behavior after an analog of ACTH 4-9, evidence for an attentional alteration

dc.contributor.authorChudler, R.en_US
dc.contributor.authorKatz, Richard J.en_US
dc.date.accessioned2006-09-11T17:45:32Z
dc.date.available2006-09-11T17:45:32Z
dc.date.issued1980-11en_US
dc.identifier.citationKatz, R. J.; Chudler, R.; (1980). "Y-Maze behavior after an analog of ACTH 4-9, evidence for an attentional alteration." Psychopharmacology 71(1): 95-96. <http://hdl.handle.net/2027.42/46418>en_US
dc.identifier.issn0033-3158en_US
dc.identifier.issn1432-2072en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/46418
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=6256793&dopt=citationen_US
dc.description.abstractAdult, male, Swiss-Webster mice were injected with either control solution or various doses of a long-acting analog of ACTH 4-9. The drug produced significant alterations in performance in an equiangular Y-maze. In comparison with control performance, both 25 and 50 μg/kg of drug produced a significant increase in repeated two-arm entries. This response pattern is consistent with the hypothesis that the drug produced a focusing of attention.en_US
dc.format.extent200532 bytes
dc.format.extent3115 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherSpringer-Verlagen_US
dc.subject.otherAttentionen_US
dc.subject.otherBiomedicineen_US
dc.subject.otherPsychiatryen_US
dc.subject.otherPharmacology/Toxicologyen_US
dc.subject.otherACTH 4-9en_US
dc.subject.otherY-maze Performanceen_US
dc.titleY-Maze behavior after an analog of ACTH 4-9, evidence for an attentional alterationen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelPsychiatryen_US
dc.subject.hlbsecondlevelNeurosciencesen_US
dc.subject.hlbsecondlevelChemistryen_US
dc.subject.hlbsecondlevelBiological Chemistryen_US
dc.subject.hlbtoplevelScienceen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumMental Health Research Institute, Department of Psychiatry, University of Michigan Medical Center, 48109, Ann Arbor, Michigan, USAen_US
dc.contributor.affiliationumMental Health Research Institute, Department of Psychiatry, University of Michigan Medical Center, 48109, Ann Arbor, Michigan, USAen_US
dc.contributor.affiliationumcampusAnn Arboren_US
dc.identifier.pmid6256793en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/46418/1/213_2004_Article_BF00433260.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1007/BF00433260en_US
dc.identifier.sourcePsychopharmacologyen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
213_2004_Article_BF00433260.pdf
Size:
195.8KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.